Of the Kurdistan Region’s 3,300 thalassemia patients, nearly 500 have Hepatitis B or C.
Cursor International executes projects and collaboration activities across several industries.
Of the Kurdistan Region’s 3,300 thalassemia patients, nearly 500 have Hepatitis B or C.